PRICKLE2 Gene Epilepsy progressive myoclonic type 5 Genetic Test
Test Details
The PRICKLE2 gene is associated with a rare form of epilepsy known as progressive myoclonic epilepsy type 5 (EPM5). This genetic disorder is characterized by seizures, muscle jerks (myoclonus), and progressive neurological deterioration.
NGS (Next-Generation Sequencing) is a genetic testing method that can identify mutations or changes in the DNA sequence of the PRICKLE2 gene that may be responsible for EPM5. This test involves analyzing the patient’s DNA sample to detect any variations in the gene that could be causing the disorder.
Genetic testing for EPM5 can help diagnose the condition and provide information on the specific genetic mutation that is causing the disorder. This can help guide treatment options and provide information for family planning. However, genetic testing is not always necessary for the diagnosis of EPM5 and should be discussed with a healthcare provider.
Test Name: PRICKLE2 Gene Epilepsy progressive myoclonic type 5 Genetic Test
Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
- Pre Test Information: Clinical History of Patient who is going for PRICKLE2 Gene Epilepsy, progressive myoclonic type 5 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PRICKLE2 Gene Epilepsy, progressive myoclonic type 5.
For more information or to schedule a genetic test, please contact DNA Labs UAE.
Test Name | PRICKLE2 Gene Epilepsy progressive myoclonic type 5 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for PRICKLE2 Gene Epilepsy, progressive myoclonic type 5 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PRICKLE2 Gene Epilepsy, progressive myoclonic type 5 |
Test Details |
The PRICKLE2 gene is associated with a rare form of epilepsy known as progressive myoclonic epilepsy type 5 (EPM5). This genetic disorder is characterized by seizures, muscle jerks (myoclonus), and progressive neurological deterioration. NGS (Next-Generation Sequencing) is a genetic testing method that can identify mutations or changes in the DNA sequence of the PRICKLE2 gene that may be responsible for EPM5. This test involves analyzing the patient’s DNA sample to detect any variations in the gene that could be causing the disorder. Genetic testing for EPM5 can help diagnose the condition and provide information on the specific genetic mutation that is causing the disorder. This can help guide treatment options and provide information for family planning. However, genetic testing is not always necessary for the diagnosis of EPM5 and should be discussed with a healthcare provider. |